期刊文献+

不同月份痰菌结果对含利奈唑胺方案治疗耐多药肺结核患者的结局预测 被引量:3

Evaluation of the results of sputum bacteria in different months as a predictor of treatment outcome for multidrug-resistant pulmonary tuberculosis patients with linezolid regimen
在线阅读 下载PDF
导出
摘要 目的评估不同月份痰菌结果对含利奈唑胺方案治疗的耐多药结核病患者治疗结局预测的有效性。方法选取广州市胸科医院肺结核科2014年10月1日—2017年11月1日使用含利奈唑胺方案治疗耐多药肺结患者,收集不同月份的痰涂片、痰培养结果,通过分析痰菌阴转情况,评价治疗结局预测的灵敏度、特异度和受试者工作特征曲线,比较不同月份痰菌结果对于治疗结局的预测效率。结果纳入47例患者中成功治疗40例;失败7例,其中2例死亡;成功率83.0%,十二月末痰培养转预测灵敏度(91.5%)、特异度(88.4%)、阳性预测值(95.0%)、ORC曲线下面积(0.832,P=0.005),优于三月末、六月末、九月末的相关指标,是最优的治疗结局预测指标。结论比较其他月份痰菌结果,十二月末的痰培养阴转能更有效的预测治疗结局。 Objective To evaluate the effectiveness of the results of sputum bacteria in different months in predicting the treatment outcome of MDR-TB patients treated with linezolid regimens.Methods The pulmonary tuberculosis department of Guangzhou Chest Hospital from October 1,2014 to November 1,2017 used linezolid-containing regimens to treat patients with multidrug-resistant lung nodes.Sputum smears and sputum culture results from different months were collected,the negative conversion of sputum bacteria was analyzed to evaluate the sensitivity,specificity and receiver operating characteristic curve of treatment outcome prediction,and compare the prediction efficiency of sputum bacteria results in different months for treatment outcome.Results Among 47 patients,40 were successfully treated;7 failed,and 2 of them died;the success rate was 83.0%.The sensitivity(91.5%),specificity(88.4%),positive predictive value(95.0%),the area under the ORC curve(0.832,P=0.005),which is better than the relevant indicators at the end of March,the end of June,and the end of September,and is the best predictor of treatment outcome.Conclusion Compared with the results of sputum bacteria in other months,the negative conversion of sputum culture at the end of December can more effectively predict the treatment outcome.
作者 张宏 邝浩斌 覃红娟 汪敏 吴迪 陈泽莹 袁园 冯治宇 ZHANG Hong;KUANG Haobin;QIN Hongjuan;WANG Min;WU Di;CHEN Zeying;YUAN Yuan;FENG Zhiyu(Guangzhou Chest Hospital/Guagnzhou Tuberculosis Control Institute,Guangzhou 510095,China;不详)
机构地区 广州市胸科医院
出处 《现代医院》 2021年第4期653-656,共4页 Modern Hospitals
基金 广东省转化医学创新平台培育建设项目B类(粤卫函[2018]1254号) 广州市医药卫生科技重大项目(2015A03102) 广州市临床医学研究与转换中心试点建设项目(155700012) 广州市高水平临床重点专科和培育专科建设项目(穗卫函[2019]1555号)。
关键词 痰涂片 痰培养 阴转 诊断价值 治疗结局 耐多药肺结核 利奈唑胺 Sputum Smear Sputum Culture Negative Conversion Diagnostic Value Treatment Outcome Multidrug-Resistant Tuberculosis Linezolid
作者简介 通信作者:邝浩斌。
  • 相关文献

参考文献7

二级参考文献62

  • 1World Health Organization. Global tuberculosis report 2012[R/ OL]. Switzerland:Geneva. http://www.who.int/tb/publications /global_report/en/.
  • 2Zhao Y, Xu S, Wang L, et al. National survey of drug- resistant tuberculosis in China [J]. N Engl Med, 2012,366 (23) : 2161-2170.
  • 3World Health Organization. WHO report 2011: global tuberculosis control [ R/OL ]. Switzerland : Geneva.http ://www. who.int/tb/publications/global_report/2011/gtbrl l_full.pdf.
  • 4中国全球基金结核病项目办公室.第五轮中国全球基金结核病项目一期耐多药肺结核病防治实施方案修订版[S].北京.2008.
  • 5Shean K P, Willcox P A, Siwendu S N, et al. Treatment out come and follow- up of multidrug-resistant tuberculosis patient s, West Coast/Wine lands, South Africa, 1992-2002 [J]. Int J Tuberc Lung Dis, 2008,12(10) : 1182-1189.
  • 6Bonilla C A, Crossa A, Jave H O, et al. Management of extensively drug-resistant tuberculosis in Peru: cure is possible [ J ]. PLoS ONE, 2008,3 (8) : e2957.
  • 7Masjedi M R, Tabarsi P, Chitsaz E, et al. Outcome of treatment of MDR-TB patients with standadised regimens, Iran, 2002-2006[J]. Int J Tuberc Lung Dis, 2008,12(7): 750-755.
  • 8Chiang C Y, Enarson D A, Yu M C, et al. Outcome of pulmonary multidrug resistant tuberculosis: a 6-yr follow-up study [J]. Eur Respir J, 2006,28(5) :980-985.
  • 9World Health Organization. WHO report 2009: management of MDR-TB. A field guide [ R/OL ]. Switzerland : Geneva.http :// whqlibdoc.who.int/publications/2009/9789241547765eng.pdf.
  • 10Jeon D S, Shin D O, Park S K, et al. Treatment outcome and mortality among patients with multidrug-resistant tuberculosis in tuberculosis hospitals of the public sector [J]. Korean Med Sci, 2011,26( 1 ) : 33-41.

共引文献113

同被引文献33

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部